India opener Shubman Gill, who is currently down with dengue, was hospitalised in Chennai after his platelet count dropped below 100,000 but has been subsequently released as he still remains a doubtful starter for the marquee World Cup clash against Pakistan in Ahmedabad on October 14.
Gill, who tested positive for dengue upon his arrival in Chennai last week has been down for the past week and will also miss India's second game against Afghanistan on Wednesday.
"Shubman Gill was on drip at the Chennai team hotel for the last couple of days. However his platelet count dropped to 70,000 and as it is a case with dengue patients, once the count is below 100,000, you are admitted to a medical facility as a precautionary measure. He was admitted for all mandatory tests on Sunday night when India played Australia but by Monday evening was released," a BCCI source told PTI on conditions of anonymity.
It is learnt that Gill was admitted to a Chennai's well-known multi-care speciality hospital 'Kauvery' and the Indian team's doctor Rizwan has stayed back to monitor his progress.
While there is still 96 hours left for the match against Pakistan, it will be Gill's health which will be paramount for the Indian team management as he requires to be 100 per cent fit for the marathon tournament.
A bout of dengue weakens the body considerably but even for an elite athlete, it does take time to bear the physical bump and grind of a tournament like the World Cup.
In fact skipper Rohit Sharma had said first priority for him is to see that Gill is no longer sick.
"I mean obviously, he is sick. I feel for him. But in terms of, you know, me being the human being first, I want him to get well, not the captain thinking, oh, I want Gill to play tomorrow. No, I want him to get well he you know he's a young guy he's got fit body so he'll recover he'll recover quick," Rohit has said before the game against Australia.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)